Overview
Tyrosine is a non-essential aromatic amino acid that is synthesized in the body from phenylalanine. It contains a phenolic side chain, which gives it unique biochemical properties and allows participation in multiple metabolic pathways. Tyrosine is a precursor for several important biomolecules, especially catecholamine neurotransmitters such as dopamine, norepinephrine, and epinephrine.
These compounds are essential for normal nervous system activity. Tyrosine also plays a key role in the synthesis of thyroid hormones and melanin, linking it to metabolic regulation and pigmentation. It is absorbed from the intestine, transported through the bloodstream, and can cross the blood–brain barrier, allowing it to support both peripheral and central physiological functions.
Symptoms
Symptoms related to tyrosine imbalance vary depending on whether levels are excessive or deficient. Excess tyrosine may present with liver-related manifestations such as jaundice and hepatomegaly. Neurological symptoms, including pain crises and neuropathy, can also occur.
Skeletal abnormalities like rickets and bone fragility may be seen in severe metabolic disturbances. Eye involvement, such as corneal ulcers and skin manifestations like palmoplantar keratosis, are notable feature of elevated tyrosine states.
Deficiency of tyrosine can lead to neurological and developmental symptoms. These include dystonia, tremors, hypotonia, and gait disturbances. Cognitive impairment and intellectual disability may be present in prolonged deficiency states. Autonomic symptoms such as sweating and ptosis can occur, along with ocular manifestations like oculogyric crises. These symptoms reflect the reduced availability of neurotransmitters and hormones derived from tyrosine.
Causes
Abnormal tyrosine levels are mainly caused by inherited metabolic defects affecting tyrosine metabolism. Tyrosinemia results from enzyme deficiencies that block the normal breakdown of tyrosine, leading to its accumulation and toxic byproducts. Defects in enzymes such as fumarylacetoacetate hydrolase impair downstream metabolism and cause systemic damage.
Low tyrosine levels may arise in phenylketonuria, where impaired conversion of phenylalanine to tyrosine results in deficiency. Nutritional insufficiency or inadequate protein intake can also contribute to low tyrosine levels. Secondary causes include liver dysfunction, which disrupts tyrosine metabolism and clearance.
Risk Factors
Risk factors for tyrosine imbalance include genetic inheritance of metabolic enzyme deficiencies. Newborns and infants are particularly vulnerable, as early metabolic errors can lead to severe manifestations if undetected. Family history of inborn errors of metabolism increases risk. Individuals with liver disease are also at higher risk due to impaired tyrosine breakdown. Poor dietary intake of protein-rich foods may predispose individuals to deficiency states. Lack of newborn screening can delay diagnosis, increasing the risk of complications related to abnormal tyrosine levels.
Prevention
Prevention of tyrosine-related disorders focuses on early detection and appropriate management. Newborn screening using dried blood spot samples allows early identification of metabolic abnormalities involving tyrosine.
Timely diagnosis enables dietary and clinical interventions before irreversible damage occurs. Adequate nutritional intake of protein from animal and plant sources helps maintain normal tyrosine levels.
Proper sample collection, handling, and laboratory monitoring support accurate assessment and follow-up. Clinical correlation of laboratory findings ensures early recognition of metabolic disturbances, reducing long-term complications associated with tyrosine imbalance.
